Clinical & translational oncology

• 

  Año 2024, Vol. 26, Número 12

  • REVIEW ARTICLE

    • Research advances on TIL therapy for colorectal cancer

      Jiaojiao Jiang, Wenxi Shu, Qinghua Yao

      • Resumen

      págs. 2917-2923

      

    • The role of IGF/IGF‑1R signaling in the regulation of cancer stem cells

      Fengchao Liu, Susu Ye, Liu Zhao, Qinghui Niu

      • Resumen

      págs. 2924-2934

      

    • Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

      Ramón Colomer Bosch, Blanca Gonzalez Farre, Ana Isabel Ballesteros García, V. Peg, Begoña Bermejo de las Heras, Belén Pérez Mies, Susana de la Cruz Sánchez, Federico Rojo, Sonia Pernas Simon, José Luis Palacios

      • Resumen

      págs. 2935-2951

      

  • RESEARCH ARTICLE

    • Identification of SMC2 and SMC4 as prognostic markers in breast cancer through bioinformatics analysis

      Lili Pei, Yu Li , Hao Gu, Siqi Wang, Wenhao Wu, Siyi Fan, Xiao Shi, Xinxin Si

      • Resumen

      págs. 2952-2965

      

    • A retrospective analysis of the clinicopathological features and prognostic value of MAPK12 protein expression in diffuse large B‑cell lymphoma

      Yue Liu, Han Zhang, Shu Zhao, Yue Zhang

      • Resumen

      págs. 2966-2978

      

    • ITGB4 is a prognostic biomarker and correlated with lung adenocarcinoma brain metastasis

      Jingjing Zhang, Lingjie Li, Weiwei Luo, Shenglin Ma, Yanyan Zhao

      • Resumen

      págs. 2979-2992

      

    • Survival analysis in pT1‑3 and paracolic lymph‑node invasion colorectal cancer: the prognostic role of positive paracolic lymph‑node ratio for adjuvant chemotherapy

      Xiaochuang Feng, Weilin Liao, Yuqing Tang, Xiaojiang Yi, Tieqiao Tian, Hongming Li, Jiaxin Lin, Xinquan Lu, Jin Wan, Jiahao Wang, Haijun Deng, Chuangqi Chen, Dechang Diao

      • Resumen

      págs. 2993-3002

      

    • Study of late toxicity biomarkers of locally advanced head and neck cancer patients treated with radiotherapy plus cisplatin or cetuximab points to the relevance of skin macrophages (TOX‑TTCC‑2015‑01)

      Antonio José Rullan, Juan A. Marín Jiménez, Alicia Lozano, Oriol Bermejo Segú, Lorena Arribas Hortigüela, Nuria Ruiz, Isabel Linares Galiana, Miren Taberna Sanz, Xavier Pérez, María Plana Serrahima, Marc Oliva Bernal, Ricard Mesía Nin

      • Resumen

      págs. 3003-3012

      

    • The value of combined MRI, enhanced CT and 18F‑FDG PET/CT in the diagnosis of recurrence and metastasis after surgery for ovarian cancer

      Yong Hong, Jianfeng Peng, Yanni Zeng, Xuewen Deng, Wanjun Xu, Juanting Wang

      • Resumen

      págs. 3013-3019

      

    • Efficacy and safety evaluation of combined therapies incorporating whole‑brain radiotherapy in patients with brain metastases: a systematic review and meta‑analysis

      Qi Yang, Rong Li, Jiayang Yang, Xueqi Bai, Xiudong Guo, Xin Yang, Jianbo Song

      • Resumen

      págs. 3020-3036

      

    • MKI67 with arterial hypertension predict a poor survival for prostate cancer patients, a real‑life investigation

      Yongqiang Zhou, Weihai Chen, Hao Jiang, Yuke Zhang, Zheng Ma, Zhenfan Wang, Chen Xu, Minjun Jiang, Jianchun Chen, Zhijun Cao

      • Resumen

      págs. 3037-3049

      

    • Pyrotinib as a salvage treatment for patients with HER‑2 positive advanced lung adenocarcinoma after the progression of afatinib treatment

      Manyi Xu, Yanhua Wang, Keda Shao, Yue Hao, Zhengbo Song

      • Resumen

      págs. 3050-3057

      

    • Different genetic profiles contribute to worse overall survival in patients with leptomeningeal metastases of non‑small‑cell lung cancer

      Xusheng Tang, Xiaojuan Hu, Lin Yuan, Hainan Yang, Yunfen Luo, Da Liu, Qingjun Hu, Changguo Shan, Tao Lin, Linbo Cai, Zhaoming Zhou, Xin Jin, Ming Lei, Weiping Hong

      • Resumen

      págs. 3058-3064

      

    • Clinical characteristics and prognostic analysis of metachronous bilateral breast carcinoma: a retrospective study based on propensity score matching

      Xinlei Wang, Xinrui Wang, Lijing Cai, Cong Zhang, Yuntao Li

      • Resumen

      págs. 3065-3074

      

    • Unleashing the potential: transarterial chemoembolization combined with intra‑arterial infusion of bevacizumab for unresectable hepatocellular carcinoma

      Qu Xie, Yanzhen Yang, Weiyuan Hao, Cong Luo

      • Resumen

      págs. 3075-3084

      

    • Proteo‑genomic characterization of cirrhosis‑associated liver cancers reveals potential subtypes and therapeutic targets

      Yi-- Gao-, Yang qing Liu, Hui Zhang, Meng yi Zhang

      • Resumen

      págs. 3085-3099

      

    • Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells

      Xiangkai Wei, Guoliang Zhang, Qian Liu, Zhiyuan Niu, Chunhong Chu, Chenxue Liu, Ke Wang, Lanxin Li, Rui Wang, Wenrui Cui, Huixia Xu, Chenyang Liu, Ying Wang, Lei An

      • Resumen

      págs. 3100-3115

      

    • Early diagnostic value of ECT whole‑body bone imaging combined with PINP and β‑CTX for bone metastasis of lung cancer

      Meiying Jiang, Qiyun Yu, Haitao Mei, Yingchao Jian, Rong Xu

      • Resumen

      págs. 3116-3123

      

    • Multi‑index comprehensive evaluation of the efcacy and response mechanism of immunotherapy in non‑small cell lung cancer

      Jieqiong Fan, Tao Zhang

      • Resumen

      págs. 3124-3130

      

    • Retrospective registry of patients with locally advanced/metastatic HR+/HER2− breast cancer treated in clinical practice in Andalusia

      Natalia Chavarría Piudo, Isabel Blancas López-Barajas, E. González Flores, F. Henao Carrasco, Pilar López Álvarez, David Morales Pancorbo, Salvador Gámez Casado, María de la Cabeza Lomas Garrido, José Manuel Rodríguez García, Antonia Martínez Guisado, Adrián Sánchez Vegas, M. Ruiz Borrego

      • Resumen

      págs. 3131-3141

      

    • Clinical efects of re‑evaluating a lung SBRT failure mode and efects analysis in a radiotherapy department

      Sergi Benavente, Alexandra Giraldo, Alejandro Seoane, Mónica Ramos, R. Vergés

      • Resumen

      págs. 3142-3149

      

    • LC–MS metabolomics analysis of serum metabolites during neoadjuvant chemoradiotherapy in locally advanced rectal cancer

      Qiliang Peng, Lili Jiang, Yi Shen, Yao Xu, Xinan Shen, Li Zou, Yaqun Zhu, Yuntian Shen

      • Resumen

      págs. 3150-3168

      

    • Constructing a prognostic model for colorectal cancer with synchronous liver metastases after preoperative chemotherapy: a study based on SEER and an external validation cohort

      Yixin Ding, Xiaoxi Han, Sufen Zhao, Shasha Wang, Jing Guo, Chuanyu Leng, Xiangxue Li, Kongjia Wang, Wensheng Qiu, Weiwei Qi

      • Resumen

      págs. 3169-3190

      

    • Dynamic change of gut microbiota in head and neck concurrent chemoradiotherapy patients and its potential value in the prediction of acute oral mucositis grade as well as quality of life

      Ying Chen, Xianghua Ye, Xinke Li, Fang Wang, Jinsong Yang, Xiaoli Sun, Senxiang Yan

      • Resumen

      págs. 3191-3201

      

    • Efcacy and safety of metronomic oral vinorelbine and its combination therapy as second‑ and later‑line regimens for advanced non‑small‑cell lung cancer: a retrospective analysis

      ShiJie Chen, ZhiYong He, MeiFang Li, LiHong Weng, JingHui Lin

      • Resumen

      págs. 3202-3210

      

    • Prognostic value of systemic infammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line

      Jaime Espinós Jiménez, José Manuel Aramendía Beitia, Antonio González Martín, Marta Santisteban Eslava, M.L. Sánchez Lorenzo, Ángel Vizcay Atienza, José Angel Mínguez Milio, Juan Luis Alcázar Zambrano

      • Resumen

      págs. 3211-3217

      

    • Advanced non‑squamous NSCLC with no actionable oncogenic driver in Spain: a cross‑sectional descriptive analysis of data from the Thoracic Tumor Registry

      Enric Carcereny Costa, Delvys Rodríguez Abreu, R. Lopez Castro, Fernando Fabio Franco Pérez, María Guirado, Bartomeu Massuti Sureda, Manuel Cobo Dols, Ana Blasco Cordellat, Guillermo Suay, Edel del Barco Morillo, Ana Laura Ortega Granados, Maria Ángeles Sala Gonzalez, Patricia Cordeiro González, Reyes Bernabé-Caro, José Luis González Larriba, Joaquim Bosch Barrera, Julia Calzas Rodríguez, Joaquín Casal Rubio, Airam Padilla Álvarez, A. Sánchez, Mariano Provencio Pulla

      • Resumen

      págs. 3218-3225

      

    • Thrombosis and infections associated with PICC in onco‑hematological patients, what is their relevance?

      M. Sánchez Cánovas, Esmeralda García Torralba, Noel Blaya Boluda, Ana Sánchez Saura, Gabriel Puche, Ana Sánchez, Lorena Martínez Montesinos, Carmen Poveda Ganga, Lucía García Tomas, Josefa Bayona Jiménez, Ángeles Cos Zapata, Carmen María Muñoz Jurado, Inmaculada Pina Mingorance, Amor Caravaca Hernández, Vicente Vicente García, Francisco Ayala de la Peña

      • Resumen

      págs. 3226-3235

      

    • The clinical features and prognostic implications of the co‑mutated TP53 gene in advanced non‑small cell lung cancer

      Bing Bai, Xia An, Qinghui Qu, Xin Liu, Yuanyuan Liu, Li Wei

      • Resumen

      págs. 3236-3245

      

    • Stereotactic ablative radiotherapy (SABR) for patients with lung tumor and severe pulmonary function impairment

      Abraham André Arturo Geng Cahuayme, Blanca Peregrín Pastor, Mónica Ramos, Enar Recalde, Juan Sebastián Parada Zuluaga, Jorge Luis Giralt López de Sagredo, Javier Maldonado Pijoan, Alexandra Giraldo Marín

      • Resumen

      págs. 3246-3251